Marijuana, like most mind altering substances that are used in moderation may not impact one’s life negatively. Yet, heavy cannabis use can lead to dependence and has been shown to negatively affect people cognitively, especially young people. On the other hand, the drug has shown a lot of promise in managing patient pain, stimulating the appetites of cancer patients undergoing chemo and could lead to groundbreaking seizure medications.
With three sets of conflicting views about the drug, all of which being valid (at least partially), it can be difficult to form an opinion about how the drug should be classified. It is a question that some voters are going to be asked to answer just one week from today. It is fair to say that November 8, 2016, could be a pivotal moment affecting the future of marijuana in America.
There are currently 25 states with medical marijuana programs, with more expected to hop on board next week. Four states have already legalized marijuana for adult recreational use, despite the fact that the drug is illegal on the Federal level. Five more states will consider legalizing the recreational use of pot next Tuesday, including:
Towards the end of last month, an international team of researchers presented the first atomic-level image of the human 'marijuana receptor,' according to a press release from The Scripps Research Institute (TSRI). The findings could help us better understand why some molecules related to THC are sometimes harmful. On the other hand, the research could lead to the creation of new drugs for treating:
The new study, was published by the journal Cell.